Evidence on the pharmacological treatment of ADHD
Duration: 23 mins
Publication Date: 9 Jul 2024
Next Review Date: 9 Jul 2027
DOI: 10.13056/acamh.13686
Description
In this talk, Professor Samuele Cortese discusses current pharmacological treatments for ADHD, referencing the latest NICE guidelines and a significant European ADHD Guidelines Group network meta-analysis. He explores the efficacy and tolerability of ADHD medications, specifically comparing stimulants like methylphenidate and amphetamines. The analysis addresses both short-term effects and long-term implications, highlighting the importance of balancing efficacy with tolerability in clinical practice.
Learning Objectives
A. To understand the sequence of pharmacological treatments for ADHD as recommended by NICE guidelines, starting with methylphenidate. B. To evaluate the efficacy and tolerability of different ADHD medications using network meta-analysis findings. C. To assess the long-term effects of ADHD medications on quality of life and other serious outcomes through meta-analysis and observational studies.
Related Content Links
Join Professor Samuele Cortese, one of the world’s most influential researchers of the past decade, for a comprehensive 4-hour clinical expert session on ADHD, designed specifically for mental health professionals working with children, adolescents, and families.
Explore the EBI-ADHD platform bringing together research on treatment effectiveness and safety
